HPV is a leading cause of cervical cancer in women, but 50% of people who develop the cancer are never tested. A self-collection test could help.

India has launched two HPV test kits as a step forward in combating cervical cancer, the second most common type of cancer ...

Menopause marks the end of a woman’s childbearing years, but it doesn’t mark the end of the need for a particular screening ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

The newly validated HPV Test kits use a chip-based real-time PCR (RT-PCR) technique, which is known for its accuracy and speed.

Indigenously developed HPV test kits are set to become a game-changer in India’s efforts to tackle cervical cancer, one of ...

Research Use Only (RUO) sample-sparing MULTI-ARRAY serology immunoassays have been developed for human antibodies to several HPV-16 early antigens. These assays are intended to support research of ...

[15] Samples were analyzed in triplicate in three independent PCR assays. The viruses hMPV, PIV-1, PIV-2 and PIV-3 were quantified by LightMix assays (TIB MOLBIOL, Berlin, Germany). The virus ...

Primary MDS, CMML and AML mononuclear cells (N=11, with numerous mutations) were treated with monoclonal S100A8/9 neutralizing antibodies and grown in clonogenic assays. Neutralization of S100A8/9 led ...